Correlation Between Sk Biopharmaceutica and Polaris Office

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and Polaris Office at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and Polaris Office into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sk Biopharmaceuticals Co and Polaris Office Corp, you can compare the effects of market volatilities on Sk Biopharmaceutica and Polaris Office and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of Polaris Office. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and Polaris Office.

Diversification Opportunities for Sk Biopharmaceutica and Polaris Office

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between 326030 and Polaris is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and Polaris Office Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polaris Office Corp and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with Polaris Office. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polaris Office Corp has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and Polaris Office go up and down completely randomly.

Pair Corralation between Sk Biopharmaceutica and Polaris Office

Assuming the 90 days trading horizon Sk Biopharmaceuticals Co is expected to generate 0.67 times more return on investment than Polaris Office. However, Sk Biopharmaceuticals Co is 1.49 times less risky than Polaris Office. It trades about 0.07 of its potential returns per unit of risk. Polaris Office Corp is currently generating about -0.01 per unit of risk. If you would invest  10,470,000  in Sk Biopharmaceuticals Co on October 24, 2024 and sell it today you would earn a total of  300,000  from holding Sk Biopharmaceuticals Co or generate 2.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sk Biopharmaceuticals Co  vs.  Polaris Office Corp

 Performance 
       Timeline  
Sk Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Polaris Office Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Polaris Office Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Polaris Office sustained solid returns over the last few months and may actually be approaching a breakup point.

Sk Biopharmaceutica and Polaris Office Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sk Biopharmaceutica and Polaris Office

The main advantage of trading using opposite Sk Biopharmaceutica and Polaris Office positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, Polaris Office can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polaris Office will offset losses from the drop in Polaris Office's long position.
The idea behind Sk Biopharmaceuticals Co and Polaris Office Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges